{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:42:49Z","timestamp":1794138169724,"version":"4.8.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s12028-015-0162-5","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T15:37:08Z","timestamp":1438184228000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Neuroleptic Malignant Syndrome: Complications, Outcomes, and Mortality"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-5250","authenticated-orcid":false,"given":"Sumul","family":"Modi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devanshi","family":"Dharaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonni","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Varelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"issue":"1","key":"162_CR1","first-page":"145","volume":"118","author":"J Delay","year":"1960","unstructured":"Delay J, Pichot P, Lemperiere T, Elissalde B, Peigne F. A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses. Ann Med Psychol. 1960;118(1):145\u201352.","journal-title":"Ann Med Psychol"},{"key":"162_CR2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","volume":"142","author":"JL Levenson","year":"1985","unstructured":"Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137\u201345.","journal-title":"Am J Psychiatry"},{"key":"162_CR3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3928\/0048-5713-19910301-05","volume":"21","author":"SN Caroff","year":"1991","unstructured":"Caroff SN, Mann SC, Lazarus A, Sullivan K, MacFadden W. Neuroleptic malignant syndrome: diagnostic issues. Psychiatr Ann. 1991;21:130\u201347.","journal-title":"Psychiatr Ann"},{"key":"162_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","volume":"77","author":"SN Caroff","year":"1993","unstructured":"Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77:185\u2013202.","journal-title":"Med Clin North Am"},{"key":"162_CR5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00023210-200923060-00003","volume":"23","author":"JN Trollor","year":"2009","unstructured":"Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477\u201392.","journal-title":"CNS Drugs"},{"key":"162_CR6","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.1989.00390090009002","volume":"149","author":"MR Rosenberg","year":"1989","unstructured":"Rosenberg MR, Green M. Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med. 1989;149:1927\u201331.","journal-title":"Arch Intern Med"},{"key":"162_CR7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","volume":"22","author":"G Addonizio","year":"1987","unstructured":"Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry. 1987;22:1004\u201320.","journal-title":"Biol Psychiatry"},{"key":"162_CR8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.md.0000188565.48918.41","volume":"84","author":"G Melli","year":"2005","unstructured":"Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine. 2005;84:377\u201385.","journal-title":"Medicine"},{"key":"162_CR9","first-page":"193","volume":"19","author":"N Taniguchi","year":"1997","unstructured":"Taniguchi N, Tanii H, Nishikawa T, et al. Classification system of complications in neuroleptic malignant syndrome. Methods Find Exp Clin Pharmacol. 1997;19:193\u20139.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"162_CR10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","volume":"164","author":"JR Strawn","year":"2007","unstructured":"Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J psychiatry. 2007;164:870\u20136.","journal-title":"Am J psychiatry"},{"key":"162_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/bja\/85.1.129","volume":"85","author":"P Adnet","year":"2000","unstructured":"Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth. 2000;85:129\u201335.","journal-title":"Br J Anaesth"},{"key":"162_CR12","first-page":"421","volume":"56","author":"WR Gibb","year":"1985","unstructured":"Gibb WR, Lees AJ. The neuroleptic malignant syndrome\u2014a review. Q J Med. 1985;56:421\u20139.","journal-title":"Q J Med"},{"key":"162_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4088\/JCP.10m06791","volume":"73","author":"M Nakamura","year":"2012","unstructured":"Nakamura M, Yasunaga H, Miyata H, Shimada T, Horiguchi H, Matsuda S. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese diagnosis procedure combination database. J Clin Psychiatry. 2012;73:427\u201330.","journal-title":"J Clin Psychiatry"},{"key":"162_CR14","first-page":"18","volume":"50","author":"A Shalev","year":"1989","unstructured":"Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry. 1989;50:18\u201325.","journal-title":"J Clin Psychiatry"},{"key":"162_CR15","first-page":"79","volume":"41","author":"SN Caroff","year":"1980","unstructured":"Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatr. 1980;41:79\u201383.","journal-title":"J Clin Psychiatr"},{"key":"162_CR16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.1986.tb02694.x","volume":"73","author":"A Shalev","year":"1986","unstructured":"Shalev A, Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand. 1986;73:337\u201347.","journal-title":"Acta Psychiatr Scand"},{"key":"162_CR17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/070674378603100715","volume":"31","author":"A Lazarus","year":"1986","unstructured":"Lazarus A. The neuroleptic malignant syndrome: a review. Can J Psychiatry. 1986;31:670\u20134.","journal-title":"Can J Psychiatry"},{"key":"162_CR18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1056\/NEJM197410172911601","volume":"291","author":"RA Grossman","year":"1974","unstructured":"Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. New Engl J Med. 1974;291:807\u201311.","journal-title":"New Engl J Med"},{"key":"162_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08860220500461252","volume":"28","author":"T Sanai","year":"2006","unstructured":"Sanai T, Matsui R, Hirano T, et al. Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure. Ren Fail. 2006;28:51\u20135.","journal-title":"Ren Fail"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-015-0162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-015-0162-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-015-0162-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:14:44Z","timestamp":1559427284000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-015-0162-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1007\/s12028-015-0162-5","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}